Zentalis Pharmaceuticals, Inc. (ZNTL) NASDAQ

3.48

-0.01(-0.29%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap215.37M
Enterprise Value221.05M
P/E Ratio-1.54
PEG Ratio-0.06
Price/Sales Ratio9.36
Price/Book Ratio0.91
Enterprise/Revenue9.36
Enterprise/EBITDA-1.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-6.06
Operating Margin-6.81

Management Effectiveness

Return On Assets-0.46
Return On Equity-0.52

Income Statement

Revenue67.43M
Revenue/Share0.37
Gross Profit67.43M
EBITDA-186.17M
Net Income-165.84M
Diluted EPS-2.33

Balance Sheet

Total Cash280.7M
Total Cash/Share4.21
Total Debt36.71M
Total Debt/Equity0.14
Current Ratio7.99
Book Value Per Share3.81

Price History

52-Week Change35.94
52-Week High3.95
52-Week Low1.01
Moving Average 50 Days1.52
Moving Average 200 Days1.47

Statistics

Average Volume1.3M
Shares Outstanding72.25M
% Held by Institutions73.3

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A